- cross-posted to:
- science@lemmy.world
- cross-posted to:
- science@lemmy.world
A hormone-free pill, called YCT-529, that temporarily stops sperm production by blocking a vitamin A metabolite has just concluded its first safety trial in humans, getting a step closer to increasing male contraceptive options
They do. However, those side effects are being compared to the alternative - pregnancy can be a major health risk for a woman.
Men don’t have that comparison to justify the side effects against.
It takes two to make a baby.
Putting the whole burden on the ones with ovaries (that are already a big fucking burden on their own) is absurd.
I’m aware. I’m saying from the standpoint of medical science, that’s the benchmark being used.
Organism 1 taking Med A causes health issues. Not taking Med A suffers no ill effects.
Organism 2 taking Med B causes health issues. Not taking Med B could suffer worse I’ll effects.
Approving Med A to be taken by Organism 1 in order to prevent Organism 2 from suffering ill effects…is not how medication testing is done.
Yes, but if at some point the benchmark being used is obviously, undoubtedly flawed on a matter that can be solved, then it’s time to ignore the benchmark.
The medical sector is always loooving to make exceptions and ignore rules, but when it comes to women’s health suddenly the protocol is set in stone, that seems pretty convenient for a sector that is pretty well known to be extremely set in their sexist ways.